Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis.
Medina JF.
Dig Dis. 2011;29(1):103-12. Epub 2011 Jun 17. Review.
Related citations
Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates.
Poupon R.
Dig Dis. 2011;29(1):85-8. Epub 2011 Jun 17.
Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy.
Williamson C, Miragoli M, Sheikh Abdul Kadir S, Abu-Hayyeh S, Papacleovoulou G, Geenes V, Gorelik J.
Dig Dis. 2011;29(1):58-61. Epub 2011 Jun 17. Review.
Pathophysiology of non-alcoholic steatohepatitis and basis for treatment.
Pinzani M.
Dig Dis. 2011;29(2):243-8. Epub 2011 Jul 5. Review.
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology.
Dig Dis. 2011;29(3):339-64. Epub 2011 Aug 9.
Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
Lee HS.
Dig Dis. 2011;29(3):333-8. Epub 2011 Aug 9. Review.
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K.
Dig Dis. 2011;29(3):326-32. Epub 2011 Aug 9.
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.
Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H, Sakurai T.
Dig Dis. 2011;29(3):321-5. Epub 2011 Aug 9.
Future treatment option for hepatocellular carcinoma: a focus on brivanib.
Kudo M.
Dig Dis. 2011;29(3):316-20. Epub 2011 Aug 9. Review.
mTOR inhibitor for the treatment of hepatocellular carcinoma.
Dig Dis. 2011;29(3):310-5. Epub 2011 Aug 9. Review.
Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
Kim HY, Park JW.
Dig Dis. 2011;29(3):303-9. Epub 2011 Aug 9. Review.
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
Dig Dis. 2011;29(3):289-302. Epub 2011 Aug 9. Review.
Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
Yamazaki K, Masugi Y, Sakamoto M.
Dig Dis. 2011;29(3):284-8. Epub 2011 Aug 9. Review.
TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ.
Dig Dis. 2011;29(3):278-83. Epub 2011 Aug 9.
Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
Dig Dis. 2011;29(3):273-7. Epub 2011 Aug 9. Review.
Role of the hepatic parenchyma in liver transplant tolerance: a paradigm revisited.
Benseler V, Tay SS, Bowen DG, Bertolino P.
Dig Dis. 2011;29(4):391-401. doi: 10.1159/000329802. Epub 2011 Aug 30. Review.
Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Bosserhoff A, Hellerbrand C.
Dig Dis. 2011;29(4):377-83. doi: 10.1159/000329800. Epub 2011 Aug 30. Review.
ASH and NASH.
Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S.
Dig Dis. 2011;29(2):202-10. Epub 2011 Jul 5. Review.
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients.
Marschall HU, Wagner M, Zollner G, Fickert P, Lackner C, Thorell A, Trauner M.
Dig Dis. 2011;29(1):117-8. Epub 2011 Jun 17.
Targeting nuclear bile acid receptors for liver disease.
Trauner M, Baghdasaryan A, Claudel T, Fickert P, Halilbasic E, Moustafa T, Zollner G.
Dig Dis. 2011;29(1):98-102. Epub 2011 Jun 17. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on